BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 4, 2016

View Archived Issues

Avalanche Biotechnologies to acquire Annapurna Therapeutics

Read More

Starpharma reports additional preclinical results for targeted dendrimer conjugate

Read More

FDA grants fast track designation to NDI-010976 for NASH

Read More

Oricula Therapeutics receives NIH grant to support development of ORC-13661

Read More

Mersana and Takeda expand partnership to advance development of Fleximer-based ADC therapies

Read More

Bayer Schering Pharma patents GLUT-1 inhibitors

Read More

Roche discloses BACE1 inhibitors

Read More

Merck & Co. develops ROMK channel blockers

Read More

Shionogi reports ITK inhibitors

Read More

FDA grants fast track designation for emricasan as treatment of patients with NASH cirrhosis

Read More

Shareholders approve Pozen merger with Tribute Pharmaceuticals

Read More

New AAV variant transfers genes throughout the CNS in vivo

Read More

Modulate Therapeutics established to develop immunomodulator combination IMM-01

Read More

Greenville Health System and Selah Genomics launch test for risk of sudden cardiac death

Read More

Heat Biologics provides update on its HS-410 phase II bladder cancer trial

Read More

Takeda Pharmaceutical to create wholly owned consumer healthcare subsidiary

Read More

Human fallopian tube organoid model faithfully recapitulates the mucosal fold architecture

Read More

Kyorin returns Japanese rights to aclidinium/formoterol to AstraZeneca

Read More

Defibrotide deemed effective against veno-oclussive disease in phase III trial

Read More

Pfizer profiles pipeline progress of fourth quarter 2015

Read More

Exosome-encapsulated paclitaxel shows promise to treat drug-resistant cancers

Read More

FDA grants fast track designation to TapImmune's TPIV-200 for ovarian cancer

Read More

FDA advisory committee votes on Brintellix to treat cognitive dysfunction in MDD

Read More

Mitsubishi Tanabe Pharma updates progress of third quarter of fiscal 2015

Read More

Morphotek provides folate receptor alpha diagnostic assays for Mayo Clinic study

Read More

GeoVax Labs announces its plans to develop Zika virus vaccine

Read More

Fast Forward Pharmaceuticals begins phase II studies of FFP-104

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 4, 2026.
  • Pancreas 3D hologram

    ASCO 2026: A revolution in pancreatic cancer

    BioWorld
    At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 2, 2026
  • Liver over digital lens background

    EASL 2026: Emerging liver disease targets to watch

    BioWorld
    At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
  • Bispecific antibodies with heavy chain in green and pink, light chain in blue and yellow

    ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out

    BioWorld
    Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing